Literature DB >> 31919661

GPCR and Alcohol-Related Behaviors in Genetically Modified Mice.

Jérémie Neasta1, Emmanuel Darcq2, Jérôme Jeanblanc3, Sebastien Carnicella4, Sami Ben Hamida5.   

Abstract

G protein-coupled receptors (GPCRs) constitute the largest class of cell surface signaling receptors and regulate major neurobiological processes. Accordingly, GPCRs represent primary targets for the treatment of brain disorders. Several human genetic polymorphisms affecting GPCRs have been associated to different components of alcohol use disorder (AUD). Moreover, GPCRs have been reported to contribute to several features of alcohol-related behaviors in animal models. Besides traditional pharmacological tools, genetic-based approaches mostly aimed at deleting GPCR genes provided substantial information on how key GPCRs drive alcohol-related behaviors. In this review, we summarize the alcohol phenotypes that ensue from genetic manipulation, in particular gene deletion, of key GPCRs in rodents. We focused on GPCRs that belong to fundamental neuronal systems that have been shown as potential targets for the development of AUD treatment. Data are reviewed with particular emphasis on alcohol reward, seeking, and consumption which are behaviors that capture essential aspects of AUD. Literature survey indicates that in most cases, there is still a gap in defining the intracellular transducers and the functional crosstalk of GPCRs as well as the neuronal populations in which their signaling regulates alcohol actions. Further, the implication of only a few orphan GPCRs has been so far investigated in animal models. Combining advanced pharmacological technologies with more specific genetically modified animals and behavioral preclinical models is likely necessary to deepen our understanding in how GPCR signaling contributes to AUD and for drug discovery.

Entities:  

Keywords:  GPCR; addiction; alcohol; knockout; mice

Mesh:

Substances:

Year:  2020        PMID: 31919661      PMCID: PMC7007453          DOI: 10.1007/s13311-019-00828-y

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  117 in total

1.  [Investigation of the inhibition of the regeneration of the planarian pharynx. II. Variations of the amount of the inhibitor dependent on the species and the phase of regeneration].

Authors:  C Ziller-Sengel
Journal:  J Embryol Exp Morphol       Date:  1967-08

2.  Incorrect use of the term "cosmetic surgery".

Authors:  L M Field
Journal:  J Dermatol Surg Oncol       Date:  1988-02

Review 3.  [Pharmacotherapy of epilepsies].

Authors:  H Broeker
Journal:  Z Arztl Fortbild (Jena)       Date:  1988

4.  Cryogenic thalamotomy in Parkinson's disease.

Authors:  S Bell; K Bleazel
Journal:  Med J Aust       Date:  1967-09-09       Impact factor: 7.738

5.  Synthesis and enzymic hydroxylation of protocollagen model peptide containing a hydroxyproline residue.

Authors:  Y Kikuchi; D Fujimoto; N Tamiya
Journal:  Biochem J       Date:  1971-10       Impact factor: 3.857

6.  New technologies, old lessons--what programmed learning can teach us.

Authors:  S Marson
Journal:  Nurse Educ Today       Date:  1986-06       Impact factor: 3.442

7.  Families in Singapore.

Authors:  R Blackburn
Journal:  J R Coll Gen Pract       Date:  1971-03

8.  The effect of stasis on the venous endothelium: an ultrastructural study.

Authors:  D P Thomas; R E Merton; D J Hockley
Journal:  Br J Haematol       Date:  1983-09       Impact factor: 6.998

9.  [Hereditary origin of choanal atresia].

Authors:  A Dirlewanger
Journal:  Pract Otorhinolaryngol (Basel)       Date:  1966

10.  Progesterone, androstenedione and oestradiol content of theca and granulosa tissues of the four largest ovarian follicles during the ovulatory cycle of the hen (Gallus domesticus).

Authors:  R J Etches; C E Duke
Journal:  J Endocrinol       Date:  1984-10       Impact factor: 4.286

View more
  1 in total

1.  Physiologic, Metabolic, and Toxicologic Profile of 1,3-Butanediol.

Authors:  Cameron G McCarthy; Emily W Waigi; Gagandeep Singh; Thaddaeus R Castaneda; Blair Mell; Saroj Chakraborty; Camilla F Wenceslau; Bina Joe
Journal:  J Pharmacol Exp Ther       Date:  2021-09-14       Impact factor: 4.402

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.